An ongoing dialogue on HIV/AIDS, infectious diseases,
August 12th, 2021
Could This Be Our First Effective, Inexpensive, Widely Available Outpatient Treatment for COVID-19?
It’s fluvoxamine. This rarely used antidepressant, long off-patent, has quietly been going through high-quality clinical studies for treatment of COVID-19. It certainly won’t be endorsed or promoted by any deep-pocketed pharmaceutical company, but deserves some attention nonetheless. Here’s why I think we might finally be onto something with this “repurposed” drug, even after stumbling numerous times with […]